// EventManager.addEvent("Welcome to Evolve '21", LOREM_TEXT,"https://player.vimeo.com/video/537595557","evolve")
// copyFromRealtoFirestore();
// SpeakerManager.makeSpeaker("Dr. Dave Singh","",[],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Senthil Rajappa","",[],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Nicholas Hart","",[],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Dave Singh","",[],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Param Nair","",[],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Chris Ryerson","",["MD, FRCPC"],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Brain Allwood","",["PhD, FCP"],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Sally Singh","",["PhD, FCSP"],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Gary Lee","",[""],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Matteo Bassetti","",[""],speakerProfileLink,{})
// SpeakerManager.makeSpeaker("Dr. Kumar Prabhash","",[""],speakerProfileLink,{})
// EventManager.addEventTimeLine("event-kmde59n5","HP-Securing a Diagnosis", "Until now, there has been little consensus in terms of disease definition, diagnostic criteria and diagnostic approach for Hypersensitivity Pneumonitis (HP). More than 30 years after the last guidance, the American Thoracic Society has developed new guidelines that addresses challenges in diagnosing HP. In this talk the diagnostic approach suggested will be critically analysed. ",["speaker-kmfz0vco"],"1618666200000","35")
// EventManager.addEventTimeLine("event-kmde59n5",
// "Post TB Lung Disease-An Unexplored Entitty",
// "Up to 50% of tuberculosis (TB) survivors have some form of persistent pulmonary dysfunction despite microbiologic cure. Pulmonary dysfunction, ranges from minor abnormalities to severe breathlessness, and can increase the risk of death from respiratory cause. Furthermore, treated TB patients appear to contribute substantially to the growing burden of COPD. "
// ,["speaker-kmfz0vco"],
// "1618668300000",
// "30")
// EventManager.addEventTimeLine("event-kmde59n5",
// "The Virtual Pulmonary Rehabilitation Laboratory//Home Based Pulmonary Rehab",
// "Pulmonary rehabilitation (PR) is a proven comprehensive and multidisciplinary therapeutic strategy to improve healthcare related quality of life (HRQOL) and health care utilization in patients with COPD; however, there are multiple barriers to PR including insufficient capacity, lack of access, patient inconvenience and cost. Therefore, creative solutions to increase the availability and access of PR are necessary. This talk explores the various ways of conducting a successful and impactful virtual home based  PR.",
// ["speaker-kmfz0vco"],
// "1618670100000",
// "35")
// EventManager.addEventTimeLine("event-kmde59n5",
// "Panel Discussion on Inhaled Steroids for Early COVID-19: Can it prevent hospitalisation?",
// "Late Breaker Session",
// ["speaker-kniqdd35","speaker-knft2h6b","speaker-knhskepm","speaker-knhskho6"],
// "1618664700000",
// "25")
// EventManager.addEventTimeLine("event-kmde59n5",
// "The Rise and Fall of Medical Thoracoscopy",
// "",
// ["speaker-kmfz0vco"],
// "1618672200000",
// "30")
// EventManager.addEventTimeLine("event-kmde59n5",
// "Colistin Sparing Therapies",
// "Antimicrobial resistance is on the rise across the globe. Increasing incidence of infections due to carbapenem resistant organisms is becoming difficult to treat, due to the limited availability of therapeutic agents. This talk will focus on important advancements with the handful of recently launched new antibiotics targeting some of the current most problematic Gram-negative pathogens. ",
// ["speaker-kmfz0vco"],
// "1618674000000",
// "30")
// EventManager.addTrendingItem("event-kmde59n5", TRENDING_ITEM_TYPE.URL, "Presentation for Session 2", LOREM_TEXT, "https://vimeo.com/290674467","assets/images/video-thumb.jpg")
// VideoManager.getVideoWithTag(['covid']).then(data => console.log(data))
// VideoManager.addVideo('Tuberculosis - Use of Inhaled Corticosteroids in Children', 'A potentially serious infectious bacterial disease that mainly affects the lungs.', 'https://vimeo.com/525395281/5753ae3d66',
//     'assets/images/video-thumb.jpg', ['speaker-kmfz0vco'], ['Tuberculosis'], [{ title: 'part1', endTime: '30', startTime: '10' }])
// EventManager.addPartnerWithUs("event-kmde59n5","Clinical Trial Participation 1","LOREM_TEXT","Clinical Trial Participation sub1", "LOREM_TEXT", "/assets/images/doctors.jpg")
// EventManager.addPartnerWithUs("event-kmde59n5","Clinical Trial Participation 2","LOREM_TEXT","Clinical Trial Participation sub2", "LOREM_TEXT", "/assets/images/doctors.jpg")
// EventManager.addPartnerWithUs("event-kmde59n5","Clinical Trial Participation 3",LOREM_TEXT,"Clinical Trial Participation sub3", LOREM_TEXT, "/assets/images/doctors.jpg")
// EventManager.addPartnerWithUs("event-kmde59n5","Clinical Trial Participation 4",LOREM_TEXT,"Clinical Trial Participation sub4", LOREM_TEXT, "/assets/images/doctors.jpg")
// PollManager.addPollQuestion("event-kmde59n5",1,"HOW TO DESIGN A VIRTUAL EVENT?", ["By Understanding User", "By Thinking out of box","By doing nothing","By consulting DJ Virtual Event"])
// PollManager.addPollQuestion("event-kmde59n5",2,"HOW TO RE-DESIGN A VIRTUAL EVENT?", ["By Understanding User Again", "By Thinking inside the box","By doing nothing again","By consulting DJ Virtual Event"])
// EventManager.addTrendingItem("event-kmde59n5", TRENDING_ITEM_TYPE.PDF, "Foracort Synchrobreathe – Infoguide", "All you need to know about Synchrobreathe is right here.", "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Infoguide.pdf?alt=media&token=e38903c3-6151-400e-be09-63fb17c582f2",
//  "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Infoguide_page-0001.jpg?alt=media&token=bbc20866-efda-42c1-b3f0-ebcc94f14ebe")
// EventManager.addTrendingItem("event-kmde59n5", "TRENDING_ITEM_TYPE.PDF", "ciplamedX – Expert Views. Watch Anywhere. Watch Anytime.", "A platform to access byte-sized expert views anytime, anywhere on a wide range of topics. Explore at your time and convenience.", "https://ciplamedx.com",
//     "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2Fciplamedx-thumb.jpg?alt=media&token=673add68-c1ca-4ce7-a6c9-24f56bd4e335")
// EventManager.addTrendingItem("event-kmde59n5", TRENDING_ITEM_TYPE.PDF, "Foracort Synchrobreathe – Infoguide", "All you need to know about Synchrobreathe is right here.", "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Infoguide.pdf?alt=media&token=e38903c3-6151-400e-be09-63fb17c582f2", "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Infoguide_page-0001.jpg?alt=media&token=bbc20866-efda-42c1-b3f0-ebcc94f14ebe")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Foracort Synchrobreathe – Patient Booklet","One stop solution for patients with different needs.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Patient%20Booklet.pdf?alt=media&token=4673d8ab-21cd-4956-8862-f8ddd6a7cd71","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FForacort%20Synchrobreathe%20-%20Patient%20Booklet_page-0001.jpg?alt=media&token=3a940024-d48c-4230-9f20-dd236e6fc959")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.URL,"ciplamedX – Expert Views. Watch Anywhere. Watch Anytime.","A platform to access byte-sized expert views anytime, anywhere on a wide range of topics. Explore at your time and convenience.","https://ciplamedx.com","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2Fciplamedx-thumb.jpg?alt=media&token=673add68-c1ca-4ce7-a6c9-24f56bd4e335")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Emzumab (Omalizumab) Monograph","Emzumab is world’s 1st Biosimilar of Omalizumab. Omalizumab is the most studied, most economical and readily available biologic in India. With biologics increasingly gaining acceptance in India for Severe Asthma management, it becomes imperative for you to know more about Emzumab.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FEmzumab%20(Omalizumab)%20Monograph.pdf?alt=media&token=f6b6059f-fffb-420e-bc5e-8fcaa3209cc7","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FEmzumab%20(Omalizumab)%20Monograph_page-0001.jpg?alt=media&token=4ed9c157-b07c-48db-be69-a89b0e462fa9")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Seroflo Ciphaler Monograph","Seroflo Ciphaler is a Multidose Dry Powder Inhaler developed & designed in India by Cipla. It is to be prescribed in cases of Asthma and COPD.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FSeroflo%20Ciphaler%20Monograph.pdf?alt=media&token=b0fad441-fc13-4e33-9599-80aabfa32fb6","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FSeroflo%20Ciphaler%20Monograph_pages-to-jpg-0001.jpg?alt=media&token=6214c0a9-8550-4d61-8040-8b9438ea13e4")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Seroflo Ciphaler One Pager","Seroflo Ciphaler is a Multidose Dry Powder Inhaler and can be used as Click . Click . Inhale","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FSeroflo%20Ciphaler%20One%20Pager.pdf?alt=media&token=01d81465-eba0-4178-96df-d7b966607139","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FSeroflo%20Ciphaler%20One%20Pager.png?alt=media&token=5ab041c2-7f5f-4606-948e-6efcfc60d934")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.VIDEO,"Bronch Talk India - Brocnhiectasis Community","Bronch Talk India is a closed group forum exclusively for Bronchiectasis. It is owned by the experts for the experts to build conversations on Bronchiectasis. To get the upper hand over Bronchiectasis, it offers experts’ insights, case discussions, path breaking research and much more!  Visit at www.bronchtalkindia.com","https://player.vimeo.com/video/537204298","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2Fbronch-thumb.jpg?alt=media&token=b8d56c33-de8d-462f-81b5-a9cc970721d8")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Acute Asthma Management Booklet","A Go to guide on Guidelines update & emerging therapeutic options for management of Acute Asthma","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FAcute%20Asthma%20Management%20Booklet.pdf?alt=media&token=3a69de5b-480c-41a4-a90c-85f9a76fe74d","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FAcute%20Asthma%20Management%20Booklet_pages-to-jpg-0001.jpg?alt=media&token=97d7e517-f11d-4b93-9445-32364614d24f")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"IPF Resource Guide","Resource Guide includes comprehensive information about epidemiology, diagnosis & treatment on Idiopathic Pulmonary Fibrosis.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FIPF%20RESOURCE%20GUIDE.pdf?alt=media&token=cadabeea-48eb-4435-ad8f-6221632506e7","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FIPF%20Resource%20Guide.png?alt=media&token=0e1eceee-0ce0-4dee-ba6d-9eccade96d33")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nintib Monograph","Up to date information on Nintedanib 100mg & 150mg in Idiopathic Pulmonary Fibrosis.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNINTIB%20MONOGRAPH.pdf?alt=media&token=0adebd18-0bba-45fb-9db3-12a04f53c95d","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNINTIB%20MONOGRAPH_page-0001.jpg?alt=media&token=61469664-1c41-4191-af95-cf6a0b4a732c")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"ILD Update Booklet","Up to date information on Mycophenolate Mofetil in Interstitial Lung Disease.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FILD%20UPDATE%20BOOK.pdf?alt=media&token=7a5e2da8-69b3-446d-bf44-928120a7a8ef","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FILD%20UPDATE%20BOOK_page-0001.jpg?alt=media&token=42255493-cd00-44d6-8310-8bcda20d37fa")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 1 - GOAL Study","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%201-%20GOAL%20Study.pdf?alt=media&token=83606156-ede0-4a49-abe4-fb80b3484a13","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%201-%20GOAL%20Study_page-0001.jpg?alt=media&token=b702a0d4-fadf-49d7-b2c4-5b869f4e93d0")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 2 - Cardiac Safety","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%202%20-%20Cardiac%20Safety%20(1).pdf?alt=media&token=977a4e09-d5bb-4e32-b71f-785985bc5658","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%202%20-%20Cardiac%20Safety%20(1)_pages-to-jpg-0001.jpg?alt=media&token=23f4f9e4-c8c0-47b2-b35d-c58013574d14")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 3 - EXCEL Study","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%203%20-%20EXCEL%20Study.pdf?alt=media&token=c873d23f-8537-41c2-9686-0b2701460fd7","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%203%20-%20EXCEL%20Study_pages-to-jpg-0001.jpg?alt=media&token=1ffd1301-a35b-4711-a8cb-40c89594c80d")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 4 - TORCH Study","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%204%20-%20TORCH%20Study%20(1).pdf?alt=media&token=42d65b88-8267-40a8-befb-6f0f24c85edc","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%204%20-%20TORCH%20Study%20(1)_page-0001.jpg?alt=media&token=00c73679-3e3e-4a92-bfb5-fa7f3d8e24a9")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 5 - Smoker Asthmatics","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%205%20-%20Smoker%20Asthmatics.pdf?alt=media&token=8bff5640-8f48-4f48-950e-cc64c067358a","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%205%20-%20Smoker%20Asthmatics_page-0001.jpg?alt=media&token=3ea1a00a-02b1-4be6-bf65-31672a6534bb")
// EventManager.addTrendingItem("event-kmde59n5",TRENDING_ITEM_TYPE.PDF,"Nutshell Series Issue 6 - Cough Variant","Nutshell is a series of re-written articles/landmark studies based on SF combination. The series highlights key outcomes of the studies in gist.","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%206%20-%20Cough%20Variant.pdf?alt=media&token=275f51a1-50ab-4b34-ab56-c7a35d1204d9","https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%206%20-%20Cough%20Variant_page-0001.jpg?alt=media&token=e9a47171-da42-4a0e-811f-c108d07c2bdb")
// EventManager.addEventTimeLine(
//   "evolve",
//   "Introduction to PRIDE – Practical Guide on the use of Inhaler Devices for Asthma and COPD",
//   "",
//   [],
//   "1621773000000",
//   "10"
// );
// PollManager.addPollQuestion("evolve", 1, "HOW TO DESIGN A VIRTUAL EVENT?", [
//   "By Understanding User",
//   "By Thinking out of box",
//   "By doing nothing",
//   "By consulting DJ Virtual Event",
// ]);
// EventManager.addTrendingItem(
//   "evolve",
//   TRENDING_ITEM_TYPE.PDF,
//   "Acute Asthma Booklet - 2021",
//   "Acute Asthma Booklet - 2021",
//   "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/evolve%2Ftrending%2FAcute%20Asthma%20Booklet%20-%202021.pdf?alt=media&token=06466d46-eac2-4b93-adae-475eca3e26e0",
//   "https://firebasestorage.googleapis.com/v0/b/cipla-impact.appspot.com/o/impact2021%2Ftrending%2FNutshell%20Issue%206%20-%20Cough%20Variant_page-0001.jpg?alt=media&token=e9a47171-da42-4a0e-811f-c108d07c2bdb"
// );
// EventManager.addPartnerWithUs(
//   "evolve",
//   "Clinical Trial Participation 1",
//   "LOREM_TEXT",
//   "Clinical Trial Participation sub1",
//   "LOREM_TEXT",
//   "/assets/images/doctors.jpg"
// );
EventManager.addEvent(
  "Welcome to Orient '21",
  LOREM_TEXT,
  "https://player.vimeo.com/video/537595557",
  "orient21-26may"
);
